BDBM50373023 CHEMBL404439

SMILES: Cc1oc(nc1Cc1cccc(C[C@H]2CO[C@](C)(OC2)C(O)=O)c1)-c1ccccc1

InChI Key: InChIKey=VECHOKOQWBGLST-DQMBHMMVSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50373023   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human))	BDBM50373023 (CHEMBL404439) Show SMILES Cc1oc(nc1Cc1cccc(C[C@H]2CO[C@](C)(OC2)C(O)=O)c1)-c1ccccc1 |wU:16.21,13.13,wD:16.17,(-2.13,-25.35,;-3.43,-26.18,;-4.87,-25.64,;-5.83,-26.84,;-4.98,-28.12,;-3.49,-27.69,;-2.24,-28.62,;-.83,-28.01,;-.83,-26.46,;.5,-25.69,;1.84,-26.46,;1.84,-28.01,;3.18,-28.78,;4.51,-28.01,;4.49,-26.46,;5.83,-25.68,;7.18,-26.44,;8.51,-27.22,;7.19,-27.99,;5.86,-28.77,;7.19,-24.9,;8.53,-24.14,;5.86,-24.12,;.5,-28.78,;-7.37,-26.83,;-8.14,-28.17,;-9.68,-28.17,;-10.45,-26.84,;-9.68,-25.51,;-8.14,-25.51,)| Show InChI InChI=1S/C24H25NO5/c1-16-21(25-22(30-16)20-9-4-3-5-10-20)13-18-8-6-7-17(11-18)12-19-14-28-24(2,23(26)27)29-15-19/h3-11,19H,12-15H2,1-2H3,(H,26,27)/t19-,24+	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	3.00E+3	n/a	n/a	n/a	n/a
Nippon Shinyaku Co., Ltd Curated by ChEMBL					Assay Description Agonist activity at human PPARalpha expressed in monkey CV1 cells by transactivation assay				Bioorg Med Chem Lett 18: 2128-32 (2008) Article DOI: 10.1016/j.bmcl.2008.01.086 BindingDB Entry DOI: 10.7270/Q2K0755V
					More data for this Ligand-Target Pair
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human))	BDBM50373023 (CHEMBL404439) Show SMILES Cc1oc(nc1Cc1cccc(C[C@H]2CO[C@](C)(OC2)C(O)=O)c1)-c1ccccc1 |wU:16.21,13.13,wD:16.17,(-2.13,-25.35,;-3.43,-26.18,;-4.87,-25.64,;-5.83,-26.84,;-4.98,-28.12,;-3.49,-27.69,;-2.24,-28.62,;-.83,-28.01,;-.83,-26.46,;.5,-25.69,;1.84,-26.46,;1.84,-28.01,;3.18,-28.78,;4.51,-28.01,;4.49,-26.46,;5.83,-25.68,;7.18,-26.44,;8.51,-27.22,;7.19,-27.99,;5.86,-28.77,;7.19,-24.9,;8.53,-24.14,;5.86,-24.12,;.5,-28.78,;-7.37,-26.83,;-8.14,-28.17,;-9.68,-28.17,;-10.45,-26.84,;-9.68,-25.51,;-8.14,-25.51,)| Show InChI InChI=1S/C24H25NO5/c1-16-21(25-22(30-16)20-9-4-3-5-10-20)13-18-8-6-7-17(11-18)12-19-14-28-24(2,23(26)27)29-15-19/h3-11,19H,12-15H2,1-2H3,(H,26,27)/t19-,24+	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.00E+3	n/a	n/a	n/a	n/a
Nippon Shinyaku Co., Ltd Curated by ChEMBL					Assay Description Agonist activity at human PPARgamma expressed in monkey CV1 cells by transactivation assay				Bioorg Med Chem Lett 18: 2128-32 (2008) Article DOI: 10.1016/j.bmcl.2008.01.086 BindingDB Entry DOI: 10.7270/Q2K0755V
					More data for this Ligand-Target Pair